Sunrest Lifescience Cancels Rights Issue Due to Inadequate Minimum Subscription
Sunrest Lifescience Ltd 路 Outcome 路 11 Sept 2026, 10:54 pm
Sunrest Lifescience Cancels Rights Issue Due to Inadequate Minimum Subscription Sunrest Lifescience's Board of Directors decided on 11th Sep'26 to dissolve its rights issue and unblock applicant funds. The issue, open from 18th Aug'26 to 2nd Sep'26 and extended to 11th Sep'26, failed to achieve the mandatory minimum subscription required under issue terms and Regulation 86 of SEBI ICDR Regulations, 2018.
Original exchange filing (PDF)
More announcements from Sunrest Lifescience Ltd
- Sunrest Lifescience Limited has submitted to the Exchange, the standalone and Consolidated unaudited financial results for the half year ended September 30, 2026. 路 15 Nov 2026
- SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve Unaudited Standalone and Consolidated financial results for the Half Year ended September 30, 2026 and other business matters 路 14 Nov 2026
- Sunrest Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended on 30th September, 2026 路 20 Oct 2026
- SDD Compliance Certificate for the Quarter ended on 30th September, 2026 路 09 Oct 2026
- Sunrest Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 07, 2026. Further, the company has informed the Exchange regarding voting results. 路 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 07, 2026 路 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on September 02, 2026, has decided to extend the issue of equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share. 路 02 Sept 2026
